Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
GOSS
$10.71
-2.01%
GOSS
· Gossamer Bio, Inc.
$10.71
-0.22 (-2.01%)
At close · Oct 2
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company's existing cash and cash equivalents are not sufficient to fund operating plans for at least one year from the issuance date of these financial statements. Accordingly, these conditions raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$66.85M
Shares
6.11M
Volume · Oct 2
236.38K
Avg daily vol (16 sessions)
345.74K
All webcasts
Earnings call · FY2023 Q2
Gossamer Bio, Inc. (GOSS) Q2 2023 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue
$0
Diluted EPS
-$36.00
Net income
-$42.50M
Research materials
Open the source you need; every reader stays inside this workspace.
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed Aug 8, 2023 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 8, 2023 · complete as-filed document